Infectious Diseases and Antimicrobials

📚 03 Neonatology • 🎯 25 High-Yield MCQs • Nelson 22nd Edition Standard

Congenital and Neonatal Viral Infections

  • Congenital Cytomegalovirus (CMV): ((((NINF001)) · ((NINF012)) · ((NINF013)))):
  • Diagnostic Gold Standard: : Urine or saliva PCR/culture is preferred over blood due to higher sensitivity; blood PCR is highly specific but less sensitive ((NINF001)). Infection is defined within the first 3 weeks of life ((NINF001)).
  • Treatment: : Intravenous ganciclovir 6 mg/kg/dose every 12 hours (indicated for symptomatic CNS disease to improve hearing and neurodevelopmental outcomes), transitioning to oral valganciclovir once enteral feeds are tolerated ((NINF012)).
  • Adverse Effects: : Neutropenia and transaminitis; requires serial CBC and ALT monitoring (((NINF012)) · ((NINF016))).
  • Counseling & Prevention: : Animal studies show potential reproductive toxicity (e.g., Leydig cell tumors) ((NINF002)). CDC does not recommend restricting contact with toddlers for occupationally exposed pregnant women, but emphasizes strict hand hygiene and avoiding saliva contact ((NINF013)). Routine screening is not adopted ((NINF013)).
  • Neonatal Herpes Simplex Virus (HSV): ((((NINF003)) · ((NINF014)) · ((NINF015)) · ((NINF016)) · ((NINF017)) · ((NINF018)) · ((NINF019)))):
  • Disseminated Disease Markers: : Serum ALT >2 times the upper limit of normal is suggestive of hepatic involvement ((NINF003)).
  • Management by Maternal Presentation: : - Recurrent lesions / Prior history: Lower transmission risk due to maternal antibodies. Initial evaluation requires HSV surface cultures/PCR and HSV blood PCR ((NINF014)). Vaginal delivery is permitted if no lesions or prodromal symptoms are present at labor ((NINF018)). Suppressive acyclovir near term helps facilitate vaginal delivery ((NINF018)). - Primary maternal infection near delivery: High transmission risk, lack of maternal antibodies. Requires pre-emptive IV acyclovir for 10 days even if initial PCR/surface cultures are negative ((NINF015)).
  • Clinical Manifestations: : Skin, Eye, and Mouth (SEM) disease accounts for ~50% of cases; vesicles occur in ~90% of cases (not 50-60%) ((NINF017)). Keratoconjunctivitis can progress to chorioretinitis, cataracts, and retinopathy ((NINF017)).
  • Infection Control Exceptions: : Nursery personnel with herpetic whitlow must not care for newborns because transmission occurs despite glove use ((NINF019)). Conversely, healthcare workers with orolabial HSV may work if masked, and mothers with breast lesions may breastfeed if lesions are covered ((NINF019)).
  • Monitoring: : Requires absolute neutrophil count (ANC) monitoring during both IV ganciclovir (plus ALT) and oral acyclovir suppression therapy ((NINF016)).
  • Hepatitis C Virus (HCV): ((((NINF004)) · ((NINF005)) · ((NINF006)) · ((NINF007)) · ((NINF024)))):
  • Diagnostics & Antivirals: : Among term-approved ARVs (zidovudine, lamivudine, emtricitabine, nevirapine, raltegravir), only zidovudine has been adequately studied in preterm neonates ((NINF004)). HCV ELISA detects antibodies against c100-3, c22-3, and c33c, while the Radioimmunoblot Assay (RIBA) uniquely detects 5-5-1 alongside these three ((NINF005)). Hepatitis G virus (HGV) is diagnosed via HGV RNA PCR ((NINF007)).
  • Post-Exposure & Follow-up: : IVIG provides no benefit for HCV needle-stick or neonatal exposure because anti-HCV antibodies are excluded from pooled lots ((NINF006)). Excluded infants are definitively tested with anti-HCV antibody at ≥18 months of age ((NINF024)).
  • Other Neonatal Viral Infections & Teratogens: ((((NINF008)) · ((NINF009)) · ((NINF010)) · ((NINF011)) · ((NINF020)) · ((NINF021)) · ((NINF022)) · ((NINF023)) · ((NINF025)))):
  • Human Parechovirus (HPeV): : HPeV-3 causes severe disease in neonates <2 months, including meningoencephalitis, white matter injury mimicking HIE, and palmoplantar rash ((NINF008)).
  • Zika Virus: : Associated with fetal loss, microcephaly, arthrogryposis, and chorioretinal atrophy; pigmentary retinopathy is not a core feature ((NINF009)).
  • SARS-CoV-2: : Most neonatal infections occur via horizontal transmission from caregivers postnatally, rather than transplacentally ((NINF010)).
  • Congenital Rubella: : Presents with cataracts, PDA (machinery murmur), purpura, hepatosplenomegaly, and microcephaly; confirmed via urine culture ((NINF011)).
  • Parvovirus B19: : Causes severe fetal anemia, hydrops, and myocarditis via erythroid precursor infection, but is unlikely to cause structural congenital malformations after 20 weeks; maternal infection is not an indication for termination ((NINF020)).
  • HIV in Infants & Care: : Mothers living with HIV who choose not to breastfeed should use exclusive replacement feeding only if AFASS criteria are met, using a katori-spoon (avoid bottles) ((NINF021)). Low-risk neonates receive twice-daily zidovudine for 4–6 weeks ((NINF022)). HIV encephalopathy characteristically presents with loss of developmental milestones and cognitive decline ((NINF023)).
  • Chikungunya: : Presents with neonatal fever, irritability, rash, joint swelling, and a pathognomonic brownish nasal pigmentation (CHIK sign) during recovery ((NINF025)).